Patients with vs without significant secondary tricuspid regurgitation were found to have more pronounced right ventricular systolic dysfunction.
Researchers identified evidence trough a literature review for risk assessment, testing, and optimal medical therapy to reduce perioperative cardiovascular risk prior to noncardiac surgery.
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Patients with ankylosing spondylitis were found to be at an elevated risk of developing aortic valve regurgitation.
All-cause mortality and stroke are comparable at 30 days and one year after TAVR among patients with bicuspid and tricuspid valve stenosis.
The ACC published a focused update of the 2017 expert consensus decision pathway on the management of mitral regurgitation.
High CRP and low HDL-C levels at baseline were found to predict all-cause mortality in elderly patients who underwent TAVI.
The N-terminal pro–B-type natriuretic peptide ratio may improve prognosis in elderly patients with moderate to severe valvular heart disease.
The TriClip device may be safe and effective for lowering tricuspid regurgitation by 1 grade or more.
Atrial fibrillation, left ventricular ejection fraction (LVEF), abnormal right ventricular function, and ventricular hypertrophy were found to be associated with a greater risk for aortic valve replacement (AVR), death, or hospitalization for heart failure in patients with moderate aortic stenosis, according to a study published in The American Journal of Cardiology. In this retrospective single-center study,…